🇺🇸 FDA
Patent

US 7303881

Antigen delivery compositions and methods of use

granted A61KA61K2039/53A61K2039/55555

Quick answer

US patent 7303881 (Antigen delivery compositions and methods of use) held by PDS Biotechnology Corporation expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PDS Biotechnology Corporation
Grant date
Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/53, A61K2039/55555, A61K2039/585, A61K2039/6018